Grifols | GRFS - Attività Correnti





Attività Correnti Cambiamento Data
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
Arca Biopharma USD 355.16M 23.15M 2025-09
aTyr Pharma USD 93.01M 5.52M 2025-09
Bio Path USD 680K 1.44M 2025-06
Brainstorm Cell Therapeutics USD 508K 1.01M 2025-09
Capricor Therapeutics USD 100.95M 23.18M 2025-09
Cara Therapeutics USD 43.13M 4.18M 2025-06
Esperion Therapeutics USD 462.57M 102.11M 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Grifols EUR 6.28B 92.48M 2025-09
Immunic USD 39.27M 20.57M 2025-09
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
TherapeuticsMD USD 11.82M 303K 2024-06